These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23393131)

  • 1. Endothelial cell-specific chemotaxis receptor (ECSCR) enhances vascular endothelial growth factor (VEGF) receptor-2/kinase insert domain receptor (KDR) activation and promotes proteolysis of internalized KDR.
    Kilari S; Remadevi I; Zhao B; Pan J; Miao R; Ramchandran R; North PE; You M; Rahimi N; Wilkinson GA
    J Biol Chem; 2013 Apr; 288(15):10265-74. PubMed ID: 23393131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial cell-specific chemotaxis receptor (ecscr) promotes angioblast migration during vasculogenesis and enhances VEGF receptor sensitivity.
    Verma A; Bhattacharya R; Remadevi I; Li K; Pramanik K; Samant GV; Horswill M; Chun CZ; Zhao B; Wang E; Miao RQ; Mukhopadhyay D; Ramchandran R; Wilkinson GA
    Blood; 2010 Jun; 115(22):4614-22. PubMed ID: 20086248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VEGF-A selectively inhibits FLT1 ectodomain shedding independent of receptor activation and receptor endocytosis.
    Raikwar NS; Shibuya M; Thomas CP
    Am J Physiol Cell Physiol; 2018 Aug; 315(2):C214-C224. PubMed ID: 29719170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FMS-like tyrosine kinase 1 (FLT1) is a key regulator of fetoplacental endothelial cell migration and angiogenesis.
    Ji S; Xin H; Li Y; Su EJ
    Placenta; 2018 Oct; 70():7-14. PubMed ID: 30316329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basal Flt1 tyrosine kinase activity is a positive regulator of endothelial survival and vascularization during zebrafish embryogenesis.
    Li S; Zhou XL; Dang YY; Kwan YW; Chan SW; Leung GP; Lee SM; Hoi MP
    Biochim Biophys Acta; 2015 Feb; 1850(2):373-84. PubMed ID: 25450186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiangiogenic effect by SU5416 is partly attributable to inhibition of Flt-1 receptor signaling.
    Itokawa T; Nokihara H; Nishioka Y; Sone S; Iwamoto Y; Yamada Y; Cherrington J; McMahon G; Shibuya M; Kuwano M; Ono M
    Mol Cancer Ther; 2002 Mar; 1(5):295-302. PubMed ID: 12489845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Src kinase becomes preferentially associated with the VEGFR, KDR/Flk-1, following VEGF stimulation of vascular endothelial cells.
    Chou MT; Wang J; Fujita DJ
    BMC Biochem; 2002 Dec; 3():32. PubMed ID: 12509223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transactivation of vascular endothelial growth factor (VEGF) receptor Flk-1/KDR is involved in sphingosine 1-phosphate-stimulated phosphorylation of Akt and endothelial nitric-oxide synthase (eNOS).
    Tanimoto T; Jin ZG; Berk BC
    J Biol Chem; 2002 Nov; 277(45):42997-3001. PubMed ID: 12226078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis.
    Haspel HC; Scicli GM; McMahon G; Scicli AG
    Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterotrimeric G alpha q/G alpha 11 proteins function upstream of vascular endothelial growth factor (VEGF) receptor-2 (KDR) phosphorylation in vascular permeability factor/VEGF signaling.
    Zeng H; Zhao D; Yang S; Datta K; Mukhopadhyay D
    J Biol Chem; 2003 Jun; 278(23):20738-45. PubMed ID: 12670961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gestational diabetes mellitus is associated with increased pro-migratory activation of vascular endothelial growth factor receptor 2 and reduced expression of vascular endothelial growth factor receptor 1.
    Troncoso F; Acurio J; Herlitz K; Aguayo C; Bertoglia P; Guzman-Gutierrez E; Loyola M; Gonzalez M; Rezgaoui M; Desoye G; Escudero C
    PLoS One; 2017; 12(8):e0182509. PubMed ID: 28817576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Both Kdr and Flt1 play a vital role in hypoxia-induced Src-PLD1-PKCγ-cPLA(2) activation and retinal neovascularization.
    Singh NK; Hansen DE; Kundumani-Sridharan V; Rao GN
    Blood; 2013 Mar; 121(10):1911-23. PubMed ID: 23319572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation and translocation of PKCdelta is necessary for VEGF-induced ERK activation through KDR in HEK293T cells.
    Kuriyama M; Taniguchi T; Shirai Y; Sasaki A; Yoshimura A; Saito N
    Biochem Biophys Res Commun; 2004 Dec; 325(3):843-51. PubMed ID: 15541367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of experimental choroidal neovascularization utilizing KDR selective receptor tyrosine kinase inhibitor.
    Takeda A; Hata Y; Shiose S; Sassa Y; Honda M; Fujisawa K; Sakamoto T; Ishibashi T
    Graefes Arch Clin Exp Ophthalmol; 2003 Sep; 241(9):765-72. PubMed ID: 12937991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pro-angiogenic activity of astragaloside IV in HUVECs in vitro and zebrafish in vivo.
    Zhang Y; Hu G; Li S; Li ZH; Lam CO; Hong SJ; Kwan YW; Chan SW; Leung GP; Lee SM
    Mol Med Rep; 2012 Mar; 5(3):805-11. PubMed ID: 22179585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase C regulates FLT1 abundance and stimulates its cleavage in vascular endothelial cells with the release of a soluble PlGF/VEGF antagonist.
    Raikwar NS; Liu KZ; Thomas CP
    Exp Cell Res; 2013 Oct; 319(17):2578-87. PubMed ID: 23911939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter methylation status of VEGF receptor genes: a possible epigenetic biomarker to anticipate the efficacy of intracellular-acting VEGF-targeted drugs in cancer cells.
    Kim J; Hwang J; Jeong H; Song HJ; Shin J; Hur G; Park YW; Lee SH; Kim J
    Epigenetics; 2012 Feb; 7(2):191-200. PubMed ID: 22395469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pro-angiogenic activity of notoginsenoside R1 in human umbilical vein endothelial cells in vitro and in a chemical-induced blood vessel loss model of zebrafish in vivo.
    Yang BR; Hong SJ; Lee SM; Cong WH; Wan JB; Zhang ZR; Zhang QW; Zhang Y; Wang YT; Lin ZX
    Chin J Integr Med; 2016 Jun; 22(6):420-9. PubMed ID: 25533511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor.
    Waltenberger J; Claesson-Welsh L; Siegbahn A; Shibuya M; Heldin CH
    J Biol Chem; 1994 Oct; 269(43):26988-95. PubMed ID: 7929439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudolarix acid B inhibits angiogenesis by antagonizing the vascular endothelial growth factor-mediated anti-apoptotic effect.
    Tan WF; Zhang XW; Li MH; Yue JM; Chen Y; Lin LP; Ding J
    Eur J Pharmacol; 2004 Sep; 499(3):219-28. PubMed ID: 15381043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.